Newamsterdam Pharma Company N.V. (NAMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 1,365 | N/A | N/A |
| TOTAL | $1,869 | $N/A | $N/A |
| Non-Current Assets | |||
| Investments And Advances | 138,001 | 0 | 0 |
| TOTAL | $138,001 | $N/A | $N/A |
| Total Assets | $139,870 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 163 | 0 | 0 |
| Accrued Expenses | 74 | N/A | N/A |
| TOTAL | $237 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 145,341 | 0 | 0 |
| TOTAL | $150,171 | $N/A | $N/A |
| Total Liabilities | $150,408 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -10,539 | N/A | N/A |
| TOTAL | $-10,538 | $N/A | $N/A |
| Total Liabilities And Equity | $139,870 | $0 | $0 |